INTERSTITIAL CYSTITIS
Clinical trials for INTERSTITIAL CYSTITIS explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL CYSTITIS trials appear
Sign up with your email to follow new studies for INTERSTITIAL CYSTITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo drug aims to ease painful bladder syndrome
Symptom relief TerminatedThis study tested a single dose of URG101, a combination of lidocaine and heparin, to see if it safely reduces bladder pain in people with interstitial cystitis (painful bladder syndrome). About 91 adults with moderate-to-severe symptoms took part, and neither they nor their doct…
Matched conditions: INTERSTITIAL CYSTITIS
Phase: PHASE2 • Sponsor: Urigen • Aim: Symptom relief
Last updated May 17, 2026 04:29 UTC
-
New combo therapy aims to ease bladder pain
Symptom relief TerminatedThis study tested a bundled care approach for women with chronic bladder pain. Participants received physical therapy, behavioral health support, and standard medical care. The goal was to see if this team-based approach reduces pain and urinary symptoms better than usual care al…
Matched conditions: INTERSTITIAL CYSTITIS
Phase: PHASE3 • Sponsor: Jocelyn Fitzgerald • Aim: Symptom relief
Last updated May 17, 2026 04:26 UTC